Topic: Cancer treatment
This project is focused on overcoming the problem of relapse of melanoma in patients being treated by immunotherapy with checkpoint inhibitors.
This project aims to discover how a particular protein called BRD4 leads to the development and growth of tumours in children with TERT-rearranged neuroblastoma.
This project aims to develop a tailored treatment approach for pancreatic cancer, providing more effective options and boosting the chances of a good outcome.
This project will lead to a clinical trial of a developed test to ensure the right patients receive and benefit from focal therapy for prostate cancer.
If this treatment is shown to be effective, it will provide much-needed hope for patients who receive the devastating diagnosis of pancreatic cancer.
This project will test and validate how new technologies could be utilised to monitor the concentration of chemotherapy in a patient’s blood in real-time.
Prof David Gottlieb’s research has discovered that the treatment of using enhanced white blood cells to fight infection and leukemia can reduce side effects in bone marrow transplant recipients.
A team of researchers led by Dr Nicole Verrills has been investigating if a new ‘gene marker’ can predict which breast cancer patients may have poorer treatment outcomes.
Professor Robert Baxter and his team have tested a promising new therapy, which can effectively block the growth of triple negative breast cancer by inhibiting two proteins that act as stimulators.
This research has provided a groundbreaking insight into the relationship between the protein dyskerin
and neuroblastoma, a deadly childhood cancer.